Role of Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in inflammation and pathogen-associated interactions
Authors:
- Sarah TrutheSTSarah Truthe
- Tilman E. KlassertTKTilman E. Klassert
- Stefan SchmelzSSStefan Schmelz
- Danny JonigkDJDanny Jonigk
- Wulf BlankenfeldtWBWulf Blankenfeldt
- Hortense SlevogtHSHortense Slevogt
Open Access
- 17 January 2024
- journal article
- review article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 16 (1) , 1
Abstract
Background: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is known as a major receptor for oxidized low-density lipoproteins (oxLDL) and plays a significant role in the genesis of atherosclerosis. Recent research has shown its involvement in cancer, ischemic stroke, and diabetes. LOX-1 is a C-type lectin receptor and involved in the activation of immune cells and inflammatory processes. It may further interact with pathogens, suggesting a role in infections or the host's response. Summary: This review compiles the current knowledge of potential implications of LOX-1 in inflammatory processes and in host-pathogen interactions with a particular emphasis on its regulatory role in immune responses. Also discussed are genomic and structural variations found in LOX-1 homologues across different species as well as potential involvements of LOX-1 in inflammatory processes from the angle of different cell types and organ-specific interactions. Key messages: The results presented reveal both similar and different structures in human and murine LOX-1 and provide clues as to the possible origins of different modes of interaction. These descriptions raise concerns about the suitability, particularly of mouse models, that are often used in the analysis of its functionality in humans. Further research should also aim to better understand the mostly unknown binding and interaction mechanisms between LOX-1 and different pathogens. This pursuit will not only enhance our understanding of LOX-1 involvement in inflammatory processes, but also identify potential targets for immunomodulatory approaches.Keywords
This publication has 154 references indexed in Scilit:
- A platelet–endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1Proceedings of the National Academy of Sciences, 2000
- Upregulation of Endothelial Receptor for Oxidized Low-Density Lipoprotein (LOX-1) in Cultured Human Coronary Artery Endothelial Cells by Angiotensin II Type 1 Receptor ActivationCirculation Research, 1999
- Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene.1999
- The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatinBiochemical Pharmacology, 1999
- Genomic Organization and Regulation of Expression of the Lectin-like Oxidized Low-density Lipoprotein Receptor (LOX-1) GeneJournal of Biological Chemistry, 1998
- Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density LipoproteinArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cellsProceedings of the National Academy of Sciences, 1998
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997
- Structural Basis of Galactose Recognition by C-type Animal LectinsJournal of Biological Chemistry, 1996
- Two distinct classes of carbohydrate-recognition domains in animal lectins.Journal of Biological Chemistry, 1988